Búsqueda de Publicación - Prisma - Unidad de Bibliometría

Publicaciones en la fuente LEUKEMIA & LYMPHOMA

Tipo Año Título Fuente
Artículo2024The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA surveyLEUKEMIA & LYMPHOMA
Artículo2023Obinutuzumab plus bendamustine for relapsed/refractory chronic lymphocytic leukemia and predictive and prognostic impact of genetic alterations: the phase II GABRIELL studyLEUKEMIA & LYMPHOMA
Artículo2022Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphomaLEUKEMIA & LYMPHOMA
Revisión2022Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patientsLEUKEMIA & LYMPHOMA
Letter2019Efficacy of the combination of rituximab-bendamustine as a second-line treatment in patients with follicular lymphoma who progress after immunochemotherapy: a phase II trial of the Spanish Lymphoma Oncology GroupLEUKEMIA & LYMPHOMA
Artículo2018Characterizing patients with multiple chromosomal aberrations detected by FISH in chronic lymphocytic leukemiaLEUKEMIA & LYMPHOMA
Artículo2017The incorporation of comorbidities in the prognostication of patients with lower-risk myelodysplastic syndromeLEUKEMIA & LYMPHOMA
Artículo2017Treatment options for relapse after autograft in multiple myeloma - report from an EBMT educational meetingLEUKEMIA & LYMPHOMA
Artículo2015Fluorescence in situ hybridization of TP53 for the detection of chromosome 17 abnormalities in myelodysplastic syndromesLEUKEMIA & LYMPHOMA
Revisión2010European Myeloma Network: the 3rd Trialist Forum Consensus Statement from the European experts meeting on multiple myelomaLEUKEMIA & LYMPHOMA
Artículo2006Combined vaccination with idiotype-pulsed allogeneic dendritic cells and soluble protein idiotype for multiple myeloma patients relapsing after reduced-intensity conditioning allogeneic stem cell transplantationLEUKEMIA & LYMPHOMA
Artículo2005CD34+cell dose and outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantationLEUKEMIA & LYMPHOMA
Artículo2004Graft vs. host disease and graft vs. myeloma effect after non-myeloablative allogeneic transplantationLEUKEMIA & LYMPHOMA